Cyclo Therapeutics- Warrants (14/11/2025) Profit Margin

As of the most recent data (September 2024), CYTHW shows a profit margin of -2848.16%. That compares with -2019.93% in the prior-year period — down 41.0% year over year. That is below the Healthcare sector average of 19.13%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's profit margin is now -2848.16% (was -2019.93%) — a 41.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

The Healthcare sector average profit margin is about 19.13%. Cyclo Therapeutics- Warrants (14/11/2025) is at -2848.16%, which is lower that average. That is roughly 14987.5% below the sector mean. Use the comparison chart on this page to see how CYTHW stacks up against individual peers as well.

That compares with -2019.93% in the prior-year period — down 41.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Cyclo Therapeutics- Warrants (14/11/2025) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -2848.16%) with ownership activity and broader fundamentals.